Literature DB >> 2164794

A versatile microtiter assay for the universal cdc2 cell cycle regulator.

B Ducommun1, D Beach.   

Abstract

A microassay for p34cdc2 based on the high affinity association between cdc2 and Schizosaccharomyces pombe p13suc1 has been developed. p13 purified from Escherichia coli was immobilized on microtiter plates and cellular lysate was incubated in the wells to allow the binding of cdc2 and its associated proteins. p34cdc2 was assayed either as a histone kinase or by immunological methods. The method was optimized for S. pombe cell extracts but can also be applied to other organisms such as Xenopus oocytes or HeLa cells. This rapid assay allows the specific determination of p34cdc2 histone H1 kinase activity in a very large number of samples.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164794     DOI: 10.1016/0003-2697(90)90422-6

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Hyphal elongation is regulated independently of cell cycle in Candida albicans.

Authors:  Idit Hazan; Marisa Sepulveda-Becerra; Haoping Liu
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

2.  Inhibition of G2/M progression in Schizosaccharomyces pombe by a mutant calmodulin kinase II with constitutive activity.

Authors:  C Rasmussen; G Rasmussen
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

3.  SPO13 negatively regulates the progression of mitotic and meiotic nuclear division in Saccharomyces cerevisiae.

Authors:  R M McCarroll; R E Esposito
Journal:  Genetics       Date:  1994-09       Impact factor: 4.562

4.  The induction of the mating program in the phytopathogen Ustilago maydis is controlled by a G1 cyclin.

Authors:  Sonia Castillo-Lluva; José Pérez-Martín
Journal:  Plant Cell       Date:  2005-10-28       Impact factor: 11.277

5.  Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma.

Authors:  D H Munn; A C Beall; D Song; R W Wrenn; D C Throckmorton
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.